Atlas Trials

ZN-c3 in Adult Participants With Metastatic Colorectal Cancer

Clinical trial NCT05743036 · TERMINATED

Trial details

NCT number
NCT05743036
Sponsor
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2023-02-27
Primary completion
2024-07-16
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.